Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 1/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 5/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | F11 | P03951 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4064723 | 0.78 | PTGS2 (0.50) | DGAT1PTGS2 | |
| SCHEMBL31469288 | 0.77 | DGAT1 (0.42) | DGAT1BRD4CREBBPPTGS2F11 | |
| SCHEMBL31469232 | 0.77 | LIPG (0.40) | LPLLIPGDGAT1F11KEAP1 | |
| SCHEMBL26694207 | 0.76 | DGAT1 (0.32) | DGAT1BRD4CREBBP | |
| SCHEMBL4799731 | 0.74 | PTGS2 (0.43) | DGAT1PTGS2F11 | |
| SCHEMBL22862956 | 0.73 | DGAT1 (0.42) | DGAT1BRD4CREBBPPTGS2F11 | |
| SCHEMBL27251338 | 0.73 | BRD4 (0.33) | DGAT1BRD4CREBBP | |
| SCHEMBL9583448 | 0.71 | BRD4 (0.35) | DGAT1BRD4CREBBPPTGS2F11 | |
| SCHEMBL9583407 | 0.71 | RPS6KA5 (0.37) | DGAT1BRD4CREBBPPTGS2F11 | |
| SCHEMBL1271939 | 0.70 | IRAK4 (0.34) | LPLLIPGDGAT1BRD4CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025080784-A1 | EGFR INHIBITORS | BLUEPRINT MEDICINES CORPORATION (US) | 2025-04-17 | — | — | WO | disclosed |